MedTrace Logo

Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate

NCT02934594 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-10-17

No results posted yet for this study

Summary

Patients with metastatic spinal cord compression (MSCC) are treated with different options according to the life expectancy. Survival and surgical outcome can be influenced by surgical timing in MSCC patients treated with palliative decompression.

Conditions

  • Neoplasm Metastasis
  • Spinal Cord Compression

Interventions

OTHER

Palliative Decompression

palliative decompression to MSCC patients: before motor deficit (Group A), within 48 hours after motor deficit (Group B1), 48 hours after motor deficit (Group B2)

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shu-Hua Yang, M.D., Ph.D. · National Taiwan University Hospital

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2020-08-31
Completion
2020-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02934594 on ClinicalTrials.gov